Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA Gastrointestinal Drugs Advisory Committee

Executive Summary

FDA Gastrointestinal Drugs Advisory Committee: Meeting July 12 to discuss Lemmon's NDA 20-458 for zinc acetate for treatment of Wilson's disease and draft "Points to Consider" on H. pylori studies to prevent peptic ulcer recurrence. The meeting will take place at the Holiday Inn-Bethesda, Md., beginning at 9 a.m. A joint meeting of the GI Drugs committee with the Nonprescription Drugs Advisory Committee will take place on July 13 to discuss Glaxo's NDA 20-520 for an Rx-to-OTC switch of Zantac 75 for treatment of heartburn. The meeting begins at 8:30 a.m. in conference rooms D&E of FDA's Parklawn building...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026406

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel